Laboratory of Neurogenomiks
Cleveland Clinic
Cleveland, Estados UnidosPublicaciones en colaboración con investigadoras/es de Cleveland Clinic (5)
2018
-
Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
Biochemical Pharmacology, Vol. 157, pp. 189-201
-
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis
Neuropharmacology, Vol. 141, pp. 181-191
2016
-
Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism
Neuron, Vol. 91, Núm. 1, pp. 119-132
2014
-
White matter injury in stroke and CNS disease
Springer New York, pp. 1-592
2008
-
Interferon gamma allelic variants: Sex-biased multiple sclerosis susceptibility and gene expression
Archives of Neurology, Vol. 65, Núm. 3, pp. 349-357